Skip to search formSkip to main contentSkip to account menu

CLR1404

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

IodobenzenesPhospholipid Ethers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
SU-G-TeP3-08: Pre-Clinical Radionuclide Therapy Dosimetry in Several Pediatric Cancer Xenografts.
PURPOSE The focus of this work is to perform Monte Carlo-based dosimetry for several pediatric cancer xenografts in mice treated… 
2015
2015
Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.
Neuroblastoma (NB) is the most common extracranial solid tumor in children and is associated with high mortality in advanced… 
2015
2015
WE-EF-BRA-04: Evaluation of Dosimetric Uncertainties in Individualized Targeted Radionuclide Therapy (TRT) Treatment Planning Using Pre-Clinical Data
Purpose: Dosimetry for targeted radionuclide therapy (TRT) is moving away from conventional model-based methods towards patient… 
2012
2012
Abstract 3831: 131I-CLR1404 and CLR1404: Broad spectrum, cancer-targeted molecular radio- and chemotherapeutic phospholipid ether analogs
The effectiveness of current approaches to cancer therapy is often limited by off-target toxicity or, if relatively selective, by… 
2012
2012
Abstract 3495: The novel phospholipid ether analog CLR1404 decreases glioblastoma stem cell proliferation, suppresses GBM growth, and improves survival
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Most patients treated for glioblastoma multiforme… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)